Antibacterial Treatment of Bacterial Vaginosis: Current and Emerging Therapies

Overview

Journal Int J Womens Health

Publisher Dove Medical Press

Specialty Gynecology & Obstetrics

Date 2011 Oct 7

PMID 21976983

Citations 39

Authors

Jean-Pierre Menard

Affiliations

Soon will be listed here.

Abstract

Bacterial vaginosis is a common cause of malodorous vaginal discharge. It is also associated with sexually transmitted infections and adverse pregnancy outcomes. The magnitude of the gynecological and obstetrical consequences has stimulated therapeutic research and led to the testing of several therapies. The objective of this work is to present the currently available therapeutic strategies for the treatment of bacterial vaginosis and associated recommendations, and discuss the emerging therapies.

Citing Articles

Efficacy and safety of different drugs for the treatment of bacterial vaginosis: a systematic review and network meta-analysis.

Fan Y, Gu Y, Xian Y, Li Q, He Y, Chen K Front Cell Infect Microbiol. 2024; 14:1402346.

PMID: 39463760 PMC: 11502473. DOI: 10.3389/fcimb.2024.1402346.

Computational approach for drug discovery against Gardnerella vaginalis in quest for safer and effective treatments for bacterial vaginosis.

Fan C, Basharat Z, Mah K, Wei C Sci Rep. 2024; 14(1):17437.

PMID: 39075099 PMC: 11286753. DOI: 10.1038/s41598-024-68443-2.

Impact of Urinary Tract and Vaginal Infections on the Physical and Emotional Well-being of Women.

Ojha S, Vishwakarma P, Mishra S, Tripathi S Infect Disord Drug Targets. 2024; 25(1):e310524230589.

PMID: 38831576 DOI: 10.2174/0118715265286164240508064714.

Bacterial Vaginosis (BV) and Vaginal Microbiome Disorders in Women Suffering from Polycystic Ovary Syndrome (PCOS).

Chudzicka-Strugala I, Golebiewska I, Banaszewska B, Trzcinski M, Brudecki G, Elamin W Diagnostics (Basel). 2024; 14(4).

PMID: 38396443 PMC: 10888114. DOI: 10.3390/diagnostics14040404.

Mesh and layered electrospun fiber architectures as vehicles for Lactobacillus acidophilus and Lactobacillus crispatus intended for vaginal delivery.

Minooei F, Kanukunta A, Mahmoud M, Gilbert N, Lewis W, Lewis A Biomater Adv. 2023; 154:213614.

PMID: 37659215 PMC: 10873095. DOI: 10.1016/j.bioadv.2023.213614.

References

Svare J, Schmidt H, Hansen B, Lose G . Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections. BJOG. 2006; 113(12):1419-25. DOI: 10.1111/j.1471-0528.2006.01087.x. View

Green M, Mazur L . Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. JAMA. 1992; 268(1):92-5. View

Amsel R, Totten P, Spiegel C, Chen K, Eschenbach D, Holmes K . Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983; 74(1):14-22. DOI: 10.1016/0002-9343(83)91112-9. View

Lamont R, Sobel J, Akins R, Hassan S, Chaiworapongsa T, Kusanovic J . The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 2011; 118(5):533-49. PMC: 3055920. DOI: 10.1111/j.1471-0528.2010.02840.x. View

Howard J, Heinemann C, Thatcher B, Martin B, Gan B, Reid G . Identification of collagen-binding proteins in Lactobacillus spp. with surface-enhanced laser desorption/ionization-time of flight ProteinChip technology. Appl Environ Microbiol. 2000; 66(10):4396-400. PMC: 92315. DOI: 10.1128/AEM.66.10.4396-4400.2000. View

Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R . Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003; 35(2):131-4. DOI: 10.1016/S0928-8244(02)00465-0. View

Holley R, Richter H, Varner R, Pair L, Schwebke J . A randomized, double-blind clinical trial of vaginal acidification versus placebo for the treatment of symptomatic bacterial vaginosis. Sex Transm Dis. 2004; 31(4):236-8. DOI: 10.1097/01.olq.0000118423.20985.e7. View

Anukam K, Osazuwa E, Osemene G, Ehigiagbe F, Bruce A, Reid G . Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect. 2006; 8(12-13):2772-6. DOI: 10.1016/j.micinf.2006.08.008. View

Reichman O, Akins R, Sobel J . Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis. Sex Transm Dis. 2009; 36(11):732-4. DOI: 10.1097/OLQ.0b013e3181b08456. View

10.

Dobaria N, Mashru R . Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clindamycin phosphate. Pharm Dev Technol. 2009; 15(4):405-14. DOI: 10.3109/10837450903262058. View

11.

Strandberg K, Peterson M, Lin Y, Pack M, Chase D, Schlievert P . Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus. Antimicrob Agents Chemother. 2009; 54(2):597-601. PMC: 2812150. DOI: 10.1128/AAC.01151-09. View

12.

Braga P, Dal Sasso M, Culici M, Spallino A . Inhibitory activity of thymol on native and mature Gardnerella vaginalis biofilms: in vitro study. Arzneimittelforschung. 2010; 60(11):675-81. DOI: 10.1055/s-0031-1296346. View

13.

McDonald H, Brocklehurst P, Gordon A . Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2007; (1):CD000262. PMC: 4164464. DOI: 10.1002/14651858.CD000262.pub3. View

14.

Bradshaw C, Morton A, Hocking J, Garland S, Morris M, Moss L . High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006; 193(11):1478-86. DOI: 10.1086/503780. View

15.

Brotman R, Klebanoff M, Nansel T, Yu K, Andrews W, Zhang J . Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection. J Infect Dis. 2010; 202(12):1907-15. PMC: 3053135. DOI: 10.1086/657320. View

16.

Zeng Z, Liao Q, Yao C, Geng L, Feng L, Shi H . Directed shift of vaginal flora after topical application of sucrose gel in a phase III clinical trial: a novel treatment for bacterial vaginosis. Chin Med J (Engl). 2010; 123(15):2051-7. View

17.

Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K . Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995; 346(8974):530-6. DOI: 10.1016/s0140-6736(95)91380-7. View

18.

Faro S, Skokos C . The efficacy and safety of a single dose of Clindesse vaginal cream versus a seven-dose regimen of Cleocin vaginal cream in patients with bacterial vaginosis. Infect Dis Obstet Gynecol. 2005; 13(3):155-60. PMC: 1784567. DOI: 10.1080/10647440500148321. View

19.

Mendling W, Mailland F . Microbiological and pharmaco-toxicological profile of nifuratel and its favourable risk/benefit ratio for the treatment of vulvo-vaginal infections. A review. Arzneimittelforschung. 2002; 52(1):8-13. DOI: 10.1055/s-0031-1299849. View

20.

Schwebke J, Desmond R . A randomized trial of the duration of therapy with metronidazole plus or minus azithromycin for treatment of symptomatic bacterial vaginosis. Clin Infect Dis. 2006; 44(2):213-9. DOI: 10.1086/509577. View